(Q56592870)
Statements
Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IκB phosphorylation inhibitor) in experimental diabetic neuropathy (English)
0 references
1 reference
May 2012
0 references
94
0 references
5
0 references
1158-1165
0 references